🕵️ Aspire Biopharma Holdings, Inc. ($ASBP)
SEC insider & ownership activity, last 12 months · CIK 1847345 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 5.2% | 13G | May 15, 2026 | filing ↗ | |
| Rubenbauer Alois Ryan III | 5.0% | 13G | Jul 2, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Other events (8.01) | Jun 9, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 15, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 15, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 15, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 10, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 26, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 26, 2026 | filing ↗ |